Moderna and Pfizer Investors: There's Room For Multiple mRNA Coronavirus Vaccine Winners
Dr. Leo Nissola explains why these two stocks are both likely winners.
Full Article
Moderna and Pfizer Investors: There's Room For Multiple mRNA Coronavirus Vaccine Winners
Motley Fool
0 shares
1 views
You might like
Related news coverage
Coronavirus Vaccine Stocks: Is There Room For Multiple Winners?
Motley Fool
Pfizer and Moderna are leading the pack, but they're far from being the only companies likely to launch COVID-19 vaccines on the..
-
Pfizer And Moderna Vaccines: Here’s Everything We Know So Far – Analysis
Eurasia Review
-
US stocks rally on Moderna vaccine potential, economic recovery
Proactive Investors
-
Wall Street races ahead on Moderna vaccine potential
Proactive Investors
-
Wall Street mostly higher at the opening bell
Proactive Investors
Advertisement
More coverage
Wall Street expected to charge higher on fresh vaccine news
More promising vaccine news – this time from Moderna Inc’s (NASDAQ:MRNA) candidate – is set to lure buyers into the market..
Proactive Investors